Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (211-220 of 444) with videos related to

Pageof 45
Sort By:
Applied and Environmental Microbiology|February 27, 2023
Distinct Growth Responses of Tundra Soil Bacteria to Short-Term and Long-Term WarmingJeffrey R Propster, Egbert Schwartz, Michaela Hayer, et al.
Global Change Biology|April 6, 2019
Wildfire severity reduces richness and alters composition of soil fungal communities in boreal forests of western CanadaNicola J Day, Kari E Dunfield, Jill F Johnstone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Disease-causing mutations in the G protein β5 β-propeller disrupt its chaperonin-mediated folding trajectoryMikaila I Sass, Deirdre C Mack, Riley A Nickles, et al.
Microbiome|February 24, 2021
The bacterial communities of Alaskan mosses and their contributions to N<sub>2</sub>-fixationHannah Holland-Moritz, Julia E M Stuart, Lily R Lewis, et al.
International Journal of Obesity (2005)|June 19, 2008
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese ratsJ D Roth, J L Trevaskis, J Wilson, et al.
Investigational New Drugs|October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trialTianhong Li, Scott D Christensen, Paul H Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsH K Chew, G Somlo, P C Mack, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 21, 2011
PCDH10 is a candidate tumour suppressor gene in medulloblastomaKelsey C Bertrand, Stephen C Mack, Paul A Northcott, et al.
Kidney Cancer (Clifton, Va.)|March 12, 2019
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048Thomas J Semrad, Susan Groshen, Chunqiao Luo, et al.
Pageof 45

Showing results (211-220 of 444) with videos related to

Sort By:
Pageof 45
Applied and Environmental Microbiology|February 27, 2023
Distinct Growth Responses of Tundra Soil Bacteria to Short-Term and Long-Term WarmingJeffrey R Propster, Egbert Schwartz, Michaela Hayer, et al.
Global Change Biology|April 6, 2019
Wildfire severity reduces richness and alters composition of soil fungal communities in boreal forests of western CanadaNicola J Day, Kari E Dunfield, Jill F Johnstone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Disease-causing mutations in the G protein β5 β-propeller disrupt its chaperonin-mediated folding trajectoryMikaila I Sass, Deirdre C Mack, Riley A Nickles, et al.
Microbiome|February 24, 2021
The bacterial communities of Alaskan mosses and their contributions to N<sub>2</sub>-fixationHannah Holland-Moritz, Julia E M Stuart, Lily R Lewis, et al.
International Journal of Obesity (2005)|June 19, 2008
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese ratsJ D Roth, J L Trevaskis, J Wilson, et al.
Investigational New Drugs|October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trialTianhong Li, Scott D Christensen, Paul H Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsH K Chew, G Somlo, P C Mack, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 21, 2011
PCDH10 is a candidate tumour suppressor gene in medulloblastomaKelsey C Bertrand, Stephen C Mack, Paul A Northcott, et al.
Kidney Cancer (Clifton, Va.)|March 12, 2019
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048Thomas J Semrad, Susan Groshen, Chunqiao Luo, et al.
Pageof 45